Morgan Stanley Reiterates Overweight on Edwards Lifesciences, Maintains $102 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has reiterated an Overweight rating on Edwards Lifesciences (NYSE:EW) and maintained a $102 price target.
July 14, 2023 | 2:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Edwards Lifesciences has been reiterated as Overweight by Morgan Stanley with a maintained price target of $102.
The Overweight rating from Morgan Stanley indicates a positive outlook for Edwards Lifesciences. The maintained price target of $102 suggests that the analyst believes the stock is still undervalued, which could lead to upward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100